Form 8-K - Current report:
SEC Accession No. 0001104659-25-032684
Filing Date
2025-04-07
Accepted
2025-04-07 17:03:41
Documents
15
Period of Report
2025-04-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2511684d1_8k.htm   iXBRL 8-K 25244
2 EXHIBIT 5.1 tm2511684d1_ex5-1.htm EX-5.1 15181
3 GRAPHIC tm2511684d1_ex5-1img01.jpg GRAPHIC 3574
  Complete submission text file 0001104659-25-032684.txt   222035

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmb-20250407.xsd EX-101.SCH 3011
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20250407_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20250407_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2511684d1_8k_htm.xml XML 3553
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 25818917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)